22nd Century Group Reports Business Highlights and Financial Results for the Second Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
22nd Century Group (XXII) Reports In-Line Q2 EPS
August 5, 2021 8:00 AM EDT22nd Century Group (NYSE: XXII) reported Q2 EPS of ($0.03), in-line with the analyst estimate of ($0.03). Revenue for the quarter came in at $8.4 million, versus $6.4 million reported last year.
We remain highly confident in a positive outcome for our Modified Risk Tobacco Product (MRTP) application, and based on continued engagement and very recent feedback from the FDA, we believe that our application has completed the scientific review process and is in the documentation process, said James A. Mish, chief executive officer of 22nd Century Group. I recognize that the delay by the FDA in authorizing our... More
